JP Morgan Maintains Overweight on Allient, Raises Price Target to $95

Benzinga Newsdesk www.benzinga.com Positive 76.8%

Neg 0% Neu 0% Pos 76.8%

JP Morgan analyst Tomohiko Sano maintains Allient (NASDAQ:ALNT) with a Overweight and raises the price target from $80 to $95.